Top 50 Medical Device Startup Investors in October 2023
Top 50 Medical Device Startup Investors in October 2023
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more...Investment focus
- Health Care, Medical, Medical Device
- Seed, Pre-Seed, Convertible Note
- United States, Argentina, United Kingdom
Portfolio highlights
- Isomark Health — Isomark Health is a patented AI-based, real-time and 100% green breath technology that detects and prevents bacterial and viral infections.
- Rantizo — Rantizo provides drone spraying systems and support services for custom applicators, agribusinesses and contractors. Elevating precision ag.
- Glanris — Glanris developed a completely green, non-toxic, filtration media for water purification from an agriculture by-product. This agricultural product is grown around the world, is plentiful, and can be used locally to ensure clean drinking water in developing countries. It also gives local farmers a significant additional income source for a productthat today they are throwing away.This media has been independently tested over the last two years of development and is ready for production.
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Software, Health Care, Information Technology
- Funding Round, Seed, Series A
- Ireland, United States, United Kingdom
Portfolio highlights
- CergenX — CergenX produces cutting-edge technology for the analysis of baby brain waves that can be used to identify brain injuries early in the newborn period.
- Tailr — Redefining production for the clothing industry.
- Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Seed, Debt Financing
- United States, Israel, Denmark
Portfolio highlights
- Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
- RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
- Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Zürcher Kantonalbank - as an independent, incorporated public-law institution - is wholly owned by the canton of Zurich.
Show more...Investment focus
- Health Care, Medical Device, Biotechnology
- Seed, Series A, Funding Round
- Switzerland, Japan, Germany
Portfolio highlights
- Helio — Carbon Aware Cloud Computing.
- Tune Insight — Tune Insight orchestrates secure collaborations on sensitive data between multiple organizations to extract collective insights.
- Nagi Bioscience — Enabling small organisms testing to any lab. Unleash unique datapoints efficiently at a high-throughput rate.
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more...Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Series B
- United States, Canada, Argentina
Portfolio highlights
- Attn: Grace — Attn: Grace is a sustainable wellness brand designed for women. Starting with bladder leakage, they're creating thoughtful, more sustainable solutions for life’s inconvenient truths, one challenge at a time.
- Prime Roots — Prime Roots is on a mission to provide a better cut of meat for every type of eater. Rooted in koji, Prime Roots is able to replicate the taste and texture of meat without any of the environmental costs of animal proteins.
- Carbice Corporation — Carbice is the first no-compromise thermal interface material. It achieves all the advantages of both solid and liquid thermal interface materials without any of the pitfalls.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Health Care, Biotechnology, Software
- Series A, Seed, Funding Round
- United States, Israel, Canada
Portfolio highlights
- OOVA — OOVA is a fertility diagnostic company that spun out from Mount Sinai Hospital in New York City. Using patent pending biochemistry and artificial intelligence, OOVA learns a woman’s fertility profile by accurately measuring key hormones over time through daily urine samples. By monitoring this critical balance of hormones, OOVA can help a woman getpregnant, identify reasons she is having trouble getting pregnant, and even expose reproductive health issues like PCOS.
- Raise Green — Raise Green is the climate tech marketplace for local impact investing licensed with the SEC and FINRA to sell private securities.
- Driver Technologies — Turn your phone into a dash cam.
CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions intoregional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.
Show more...Investment focus
- Software, Health Care, Biotechnology
- Seed, Series A, Series B
- United States
Portfolio highlights
- Amify — We help brands selling on Amazon maximize sales and profitability by providing complete strategy, management and operational services.
- Tembo — CoreDB provides a fully-managed, secure, scalable Postgres cluster with access to an ecosystem of extensions, expanding the capabilities of your database.
- Voxel — Voxel utilizes advanced mathematics and artificial intelligence to rapidly generate functionally graded meta-materials for high performance applications through additive manufacturing. We provides performance leaps in the defence, automotive, aerospace, medical, industrial, and other demanding areas and unlock new capabilities for our customers.
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.
Show more...Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Funding Round
- Germany, Switzerland, United States
Portfolio highlights
- Inovedis — Inovedis offers innovative solutions in medical technology that contribute both to optimized patient care as well as time and cost reductions in the healthcare sector.
- Resourcify — Mein Recycling is developed by Resourcify GmbH from Hamburg. The app is the easiest solution for businesses to easily manage all of their waste, collections, and recyclers in one app, and for waste management companies to seamlessly connect with their customers online. Their vision is zero-waste: enabled with the digital transformation of the wastesector as the foundation for the circular economy.
- traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups
Show more...Investment focus
- Health Care, Medical Device, Medical
- Seed, Series A, Convertible Note
- United States
Portfolio highlights
- Agile Therapeutics — Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and Ethinylestradiol. The company was founded in 1997 as Levotech, Inc. and changed its name toAgile Therapeutics, Inc. in April 2001. It is based in Princeton, New Jersey.
- GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
- Wavely Diagnostics — Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more...Investment focus
- Health Care, Medical, Medical Device
- Seed, Series B, Series C
- United States, Israel
Portfolio highlights
- Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
- SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
- Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation,etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful.Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group.The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director).They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.
Show more...Investment focus
- Biotechnology, Health Care, Medical Device
- Angel, Seed, Series A
- United States, Canada, India
Portfolio highlights
- Zylö Therapeutics — Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
- Xeno Biosciences — Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts.
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Providing Flexible and Creative Financial Solutions to Life Sciences and Healthcare Services Companies.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Debt Financing, Post-IPO Debt, Series B
- United States, Canada, United Kingdom
Portfolio highlights
- Renibus Therapeutics — Renibus Therapeutics operates in the healthcare industry focusing on the pharmaceutical business. The company was incorporated in 2015 and is based in Lantana, Texas.
- ALX Oncology — ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. It is an independent, private biotechnology company.The founding of Alexo Therapeutics was based upon technology invented by Aaron Ring, K. Christopher Garcia, Kipp Weiskopf, Aron Levin, and Irving Weissman at Stanford University.This discovery involves soluble versions of signal regulatory protein-α (SIRPα) that have been engineered to bind CD47 with significantly greater affinity than natural SIRPα.1.
- Pearl Street Dental Management — Pearl Street Dental Management supports non-clinical operations. They provide centralized services such as human resources, payroll, accounting, bookkeeping, finance, lending, facilities management, and information technology services. They address inquiries through online applications, phone calls, and emails.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Biotechnology, Health Care, Software
- Seed, Series A, Series B
- United Kingdom, United States, Philippines
Portfolio highlights
- RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
North Coast Ventures (formerly North Coast Angel Fund) is comprised of four contributed capital funds with a focus on early-stage technology investments. Our membership consists of a number of Ohio's leading investors, entrepreneurs, and business leaders who are dedicated to accelerating early-stage ventures.North Coast Ventures members playan active role by generating deal flow, serving on due diligence teams, working with portfolio companies, or serving on the Investment Screening and Executive Committees. Through this involvement, our goal is to provide a supportive environment for our portfolio companies and ultimately enhance the performance of our Fund.Northeast Ohio has a long tradition of active and successful angel investing, but until recently, the success of this crucial form of funding has hinged on the efforts of a relatively small number of individual investors. As the region’s first professionally managed angel fund, North Coast Angel Fund works to improve the early-stage funding environment for both entrepreneurs and investors.
Show more...Investment focus
- Health Care, Software, Medical Device
- Series A, Seed, Funding Round
- United States
Portfolio highlights
- UnifyWork — UnifyWork's skills-based matching technology creates a faster way for employers to hire qualified talent, and helps job seekers find job opportunities meeting their skills and interests.
- Bloomfilter — Bloomfilter is a developer of an enterprise software planning application. Bloomfilter helps software executives and leaders illuminate the path to software project success through our platform.
- Vytalize Health — Vytalize Health is an all-in-one solution for independent primary care physicians participating in value-based care with Medicare. Vytalize integrates with physicians through people, technology, and unique value-based arrangements that result in better patient outcomes and better optimized care delivery.As of 2021, the company has 600+ PCPs,65K Medicare patients, and $1B in medical spending.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Health Care, Medical Device, Medical
- Grant, Pre-Seed, Seed
- United Kingdom, Spain, Ireland
Portfolio highlights
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
- Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Khosla Ventures is a venture capital firm started in 2004 by Vinod Khosla, Co-Founder of Sun Microsystems. The firm provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies.With over $15b assets under management, the firm focuses on a range of areas including consumer, enterprise, education,advertising, financial services, semiconductors, health, big data, agriculture, food, sustainable energy, and robotics. Khosla Ventures is headquartered in Menlo Park, California.
Show more...Investment focus
- Software, Health Care, Biotechnology
- Series A, Series B, Seed
- United States, India, United Kingdom
Portfolio highlights
- Arkifi — Arkifi is an artificial intelligence company that develops AI-powered financial analyst tools. Arkifi's framework generates consistent results that avoid fabricating factual details (referred to as "hallucination"), instilling enterprises with an unmatched level of confidence in the outcomes.
- Teamshares — One hundred percent close rate on LOIs. Committed capital with no financing contingency. Teamshares is the buyer of choice for your business listing. Request a buyer profile to learn more about us.
- Alias Technologies — Here at Alias Technologies our goal is to help organizations tackle complex IT goals and initiatives in an ever-changing landscape. Leveraging our Partner relationships and extensive experience we are able to help position our customers for the future.
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more...Investment focus
- Health Care, Medical, Medical Device
- Seed, Series A, Funding Round
- United States, United Kingdom, Canada
Portfolio highlights
- 32Co — 32Co is a medical technology platform that helps general dentists deliver clear aligner orthodontics to their patients.
- Essenvia — Rapidly submit eSTAR, EUMDR and IVDR applications, eliminate errors and accelerate approvals with the only regulatory submission platform made for MedTech
- Gradient Health — One of the biggest barriers to accelerating AI development is access to large datasets of labeled pathologies.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
- Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Early Stage Venture Investments
Show more...Investment focus
- Health Care, Medical Device, Software
- Seed, Convertible Note, Series A
- United States, Canada, Hungary
Portfolio highlights
- Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Series A
- United Kingdom, United States, Hungary
Portfolio highlights
- CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
- Workbuzz — Issue employee engagement surveys with WorkBuzz - a fast, simple, and flexible platform with expert consultancy. Try it now!
- Centuro Global — Centuro Global helps you go global.We help startups, scaleups & corporates enter new markets around the world. All your international expansion needs are serviced from one platform, whether you need legal support, tax & accounting, HR, opening a bank account or finding office space, we can assist across the board.Our innovativeplatform, Centuro Connect, contains blueprints on how to do business in over 150 countries, provides live chat advice, and access to local experts around the world. Instead of losing time undertaking Google searches for relevant information and identifying trusted, cost-effective service providers, find all your solutions through Centuro Connect.Come to us for services including; Legal, Immigration, Intellectual Property, Scaling & Expansion, New Market Entry, Tax & Accounting and much more.Receive advice, find service providers, investors and like minded individuals, and seamlessly grow your business.Book a free consultation with us: www.centuroglobal.com
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more...Investment focus
- Software, Health Care, Information Technology
- Funding Round, Seed, Series A
- France, United States, Switzerland
Portfolio highlights
- Nonna Lab — Make the Most. Le laboratoire qui vous rend la vie meilleure.
- Altior — Altior is an IT company that offers cloud industrial management software and ERP solution.
- Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
Maine Angels they make investments with entrepreneurs with an emphasis on businesses.
Show more...Investment focus
- Health Care, Software, Biotechnology
- Seed, Funding Round, Series A
- United States
Portfolio highlights
- HighByte — HighByte is an industrial software development company in Portland, Maine building solutions that address the data architecture and security challenges created by Industry 4.0.
- TOP the organic project — 100% Organic Cotton Period Care. Organic Tampons, Pads, First Period Kit & Bulk Period Products. Women-owned, eco-friendly, plant-based and sustainable. With every subscription, TOP gives back to women in need.
- Pumpspotting — connect over breastfeeding, milk, motherhood, and the best places to nurse and pump. nurse, pump, nourish, connect.
VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.
Show more...Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series C, Series B
- Switzerland, Germany, United States
Portfolio highlights
- Vara — Vara develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. While we provide. Vara also provides remote mammography reading services to those that lack the radiologists. Vara's mission is to make affordable diagnostics available all over the world by designing machinelearning-powered workflows that users love to work with.
- Oculis — The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billionin venture loans to thousands of companies.The company was founded in 2003 and is headquartered in Farmington, Connecticut.
Show more...Investment focus
- Health Care, Biotechnology, Medical Device
- Debt Financing, Post-IPO Debt, Funding Round
- United States, Canada, India
Portfolio highlights
- Unagi Scooters — Unagi is an electric scooter startup that aims to liberate people from the tyranny of transportation frustrations—the costs, inconveniences, the carbon emissions. So we built the ideal personal liberation device.
- Evelo Biosciences — Evelo Biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. Monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. These new medicines are broadlyapplicable across many diseases – including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. Monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. By finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, Evelo can improve the speed, cost and success of drug discovery and development. Evelo’s platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. Evelo Biosciences was conceived and created within VentureLabs®, Flagship Pioneering’s institutional innovation foundry, and launched by Flagship in 2015.
- Slingshot Aerospace — Slingshot Aerospace applies advanced analytics, machine learning, and collaborative tools to data from earth and space, providing clarity in complex environments.
Good Growth Capital specializes in finding, cultivating, and assessing complex science and deep-tech start-ups. GGC invests in seed-stage and Series A deals through the General Fund family and in pre-seed and seed-stage companies through the Infinite Corridor Fund, which primarily targets MIT-affiliated and transformative science start-ups. GGC ismajority women- and minority-owned and is uniquely positioned geographically in both the Southeast and New England.
Show more...Investment focus
- Health Care, Information Technology, Software
- Seed, Convertible Note, Series A
- United States, France, Israel
Portfolio highlights
- Pryon — Pryon is the leading AI-as-a-Service platform for content and knowledge management. Pryon closes knowledge gaps, improving employee productivity, and enhancing customer experiences. Companies such as Georgia Pacific use Pryon to improve health and safety outcomes, eliminate compliance incidents, improve employee onboarding, and upgrade all aspectsof customer service and support.
- VenoStent — VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year.
- Lemurian Labs — Lemurian Labs develops disruptive, highly parallel, ultra low-power inner-product architecture to make deep learning and computer vision applications on the edge, sustainable, resulting in higher inference throughput, a reduction in energy consumed and a decrease in heat generated from chip processing
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Switzerland, Canada
Portfolio highlights
- Kate Therapeutics — Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.
- Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
- Tentarix Biotherapeutics — Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
For over 20 years we have been a successful healthcare venture capital firm rooted in the Midwest. Check out our portfolio companies.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- United States, Canada
Portfolio highlights
- BrightSpec — LabBrightSpec addresses high-value, time-sensitive analytical chemistry challenges that are not well addressed by other spectroscopy techniques and instruments. It provides innovative laboratory services in order to deliver immediate results to potential customers of our instrumentation products. They are based in Charlottesville, Virginia,about two hours from Washington, DC. The BrightSpec Fourier transform molecular rotational resonance (FT-MRR) product platform is based on technology developed at the University of Virginia by Brooks Pate and his team, several of whom now work at BrightSpec. They offer FT-MRR product configurations for analytical chemistry and gas sensing in manufacturing process control, quality control, environmental monitoring, and formulation research.
- Boomerang Medical — Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
- Enumera Molecular — Enumera Molecular is a life science tools company headquartered in Ann Arbor, MI, developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests. It helps in transforming the field of clinical molecular testing into a simpler, more actionable tool for physicians to benefit patient care.
Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.
Show more...Investment focus
- Software, Health Care, Biotechnology
- Debt Financing, Series B, Series A
- United States, United Kingdom, Canada
Portfolio highlights
- SafeRide Health — SafeRide Health provides technology-forward non-emergency medical transportation (NEMT) services for care providers and health plans offering Medicare Advantage and Medicaid. We intelligently improve and simplify NEMT to improve health outcomes and healthcare satisfaction.
- Rainforest — Rainforest focuses on providing software platforms for payment processing. Rainforest is headquartered in Atlanta, United States.
- Olema Oncology — At Olema Oncology, we leverage our deep understanding of endocrine-driven cancers, nuclear receptors and mechanisms of acquired resistance with the goal of transforming the standard of care for women living with cancer by focusing on developing more convenient and effective therapies. Join us as we aim to design therapies for improving lives.
Bigslot288 merupakan situs slot deposit pulsa 10 ribu tanpa potongan 2022, terbukti sebagai web slot pulsa tanpa potongan terpercaya jaminan taruhan 100% aman.
Show more...Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Series B, Series C, Series A
- United States, Germany, Switzerland
Portfolio highlights
- Paperspace — Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company’s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomasssorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.
- CardioFocus — CardioFocus provides electrophysiologists with innovative and effective tools that bring precision and control to the treatment of atrial fibrillation.
- Yolia Health — Yolia Health developed The True Vision Treatment or TVT, the 'Invisalign' for the eyes. A non-invasive treatment to correct vision problems like presbyopia without surgery. TVT is self-administered by the patient in his or her own home. It employs a combination of customized contact lenses (TVT Contacts) and specially formulatedeye drops (TVT Eye Drops). After only 5 days of treatment with TVT patients are able to stop using the TVT Contacts, TVT Eye Drops and their reading glasses for up to 12 months at a time before re-treatment with TVT is needed. What is even greater than correcting for presbyopia non-invasively, is correcting both eyes without compromising any distance vision. On the contrary, Yolia's treatment improves both near and distance vision, a unique feature no single other alternative can provide. ** Looking for sophisticated investors and key industry partners.
U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the pastthirty-plus years of the firm's existence. Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.
Show more...Investment focus
- Software, Health Care, Information Technology
- Series B, Series C, Series A
- United States, Israel, Canada
Portfolio highlights
- Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
- Trust Lab — Trust Lab develops solutions to detect and mitigate online safety threats and works with social media companies, advocacy groups, and other interested parties to implement them. Palo Alto, California, U.S.A.
- Luminopia — Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One,to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Seed, Series B
- France, Spain, Switzerland
Portfolio highlights
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
- Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Funding Round, Seed, Series A
- United States, Canada, United Kingdom
Portfolio highlights
- Sequoir — Sequoir is a financial technology firm providing blockchain trading and custody APIs to power banks, credit unions, fintech, and the Web 3.0.
- Flyte — Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.
- Nurse Disrupted — A virtual nursing program that retains nurses & improves hospital finances. Live in 4 weeks. Engaged, happier nurses in days.
We’re (not just) investors.We’re (more than) advisors.We’re (beyond) connectors.Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seedstage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.
Show more...Investment focus
- Health Care, Software, Information Technology
- Seed, Grant, Debt Financing
- United States
Portfolio highlights
- Yellowdig — Yellowdig offers educators a gameful learning digital solution to improve student engagement by building learning communities.
- ImpactableX — The social impact modeling & management toolkit behind leading solutions to our world's most pressing challenges.
- GrowFlux — GrowFlux, Inc. they offers a ecosystem of commercial scale wireless lighting controls, cloud services, and cloud connected agricultural sensors.
The Foundation for Technological Innovation (FIT) has been helping startups since 1994, encourages entrepreneurship & supports innovation.
Show more...Investment focus
- Health Care, Biotechnology, Information Technology
- Debt Financing, Grant, Seed
- Switzerland, France
Portfolio highlights
- Voltiris — Voltiris filters natural sunlight to transmit it to plants and recycle the "wasted" sunlight into green electricity.
- PeriVision — Perivision combines artificial intelligence, virtual reality, and the cloud to build the next generation of systems to understand visual function. The company's systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases.
- AdVentura Works — AdVentura Works is a Swiss technology company offering material handing as a service to logistics and industrial companies
TEDCO was created by the Maryland State Legislature in 1998 to facilitate the transfer and commercialization of technology from Maryland’s research universities and federal labs into the marketplace and to assist in the creation and growth of technology-based businesses in all regions of the State. TEDCO is an independent organization thatstrives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy. In Maryland and beyond, TEDCO is a resource of mentoring, funding and networking for entrepreneurs and start-ups that need guidance as they bring innovative concepts to market. TEDCO is more than an early stage funding resource. It is the hub of Maryland’s entrepreneurial network where startups find mentors, organizational assistance, facilities for daily operations, and a roadmap for success.
Show more...Investment focus
- Software, Health Care, Biotechnology
- Seed, Pre-Seed, Series A
- United States
Portfolio highlights
- Hopr — Hopr recognizes the increasing relevance of cybersecurity in today's global digital society. Hopr objective is to assist organizations in protecting their digital operations and data by rethinking old challenges and then developing innovative cybersecurity solutions to tackle them.
- Fem Equity — Fem Equity is a work platform that develops real-time solutions for women and underrepresented professionals experiencing salary or professional inequalities.
- N5 Sensors — Sensors and solutions for protecting lives and infrastructure from environmental hazards.
For over two decades, Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.
Show more...Investment focus
- Health Care, Software, Biotechnology
- Seed, Series B, Series A
- United States, Canada, Japan
Portfolio highlights
- GaeaStar — The zero waste disposable clay cups. GaeaStar is an engineering company developing sustainable single use products and technology.
- MOGL — MOGL is created for athletes by athletes. The platform empowers all athletes to seek out opportunities to monetize their name, image, and likeness in a safe...
- PrivacyHawk — Privacyhawk is a mobile app that empowers everyone to take back control of their privacy.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Medical Device, Health Care, Medical
- Seed, Funding Round, Series A
- Ireland, United States
Portfolio highlights
- ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
- Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.
Innovate Calgary is a central innovation hub at the University of Calgary. See our programs and fundings and learn more about our innovation hubs here.
Show more...Investment focus
- Health Care, Medical, Medical Device
- Seed, Pre-Seed, Funding Round
- Canada, United States
Portfolio highlights
- MACH32 — MACH32 is a medical device startup that develops innovative solutions for new and longstanding medical problems.
- InventoRR MD — InventoRR MD focuses on commercializing groundbreaking trauma and general surgery devices that improve patient recovery outcomes, simplify procedures for doctors, and reduce costs for healthcare organizations.
- Difinity Solutions — Difinity Solutions is specializing in the development of medical devices and technology solutions.
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Series B
- United States, Israel, Sweden
Portfolio highlights
- Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
- Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
- Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Seed, Series A
- United States, Israel, The Netherlands
Portfolio highlights
- InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
- Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Israel, France
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
- ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Show more...Investment focus
- Biotechnology, Health Care, Software
- Series A, Series B, Funding Round
- France, United States, Germany
Portfolio highlights
- Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
- Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
- Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Our Entrepreneurship team (formerly the Scottish Investment Bank) helps you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Software, Biotechnology, Information Technology
- Funding Round, Seed, Series A
- United Kingdom, United States, France
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
- Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.
Show more...Investment focus
- Health Care, Medical Device, Medical
- Series A, Series B, Series C
- United States
Portfolio highlights
- Epitel — Epilog is an unobtrusive wearable seizure detection system that records long-term EEG, anywhere. It gives people living with epilepsy peace of mind with a much-needed tool to better understand and manage their seizures.
- Avive Solutions — Check out Avive Solutions, the manufacturers of a brand new AED machine - portable defibrillator - that's FDA approved!
- PanTher Therapeutics — PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatmentat the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.
Show more...Investment focus
- Health Care, Medical Device, Medical
- Series A, Series B, Series C
- United States
Portfolio highlights
- Rejoni — Rejoni uses bio-materials to develop medical devices that improve the outcome of minimally invasive and gynecological surgical procedures.
- Instylla — Instylla delivers next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.
- Avive Solutions — Check out Avive Solutions, the manufacturers of a brand new AED machine - portable defibrillator - that's FDA approved!
Mayo Clinic, a not-for-profit medical group practice, provides medical care, research, and education services. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology andheart surgery.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- United States, Israel, China
Portfolio highlights
- MEDIVIS — Medivis is a leader in AR for healthcare, using augmented reality and artificial intelligence to advance medical imaging and surgical precision.
- The Contract Network — AI-powered collaborative contracting is an innovative approach to contract negotiation that emphasizes real-time collaboration, communication, and transparency.
- Collaborative Robotics — Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction.
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Funding Round
- United States, Canada
Portfolio highlights
- Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
- Aer Therapeutics — Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.
- Mercy BioAnalytics — We are making early stage cancer 100,000x easier to find using extracellular vesicles found in blood, specific to their parent cells.
Newable helps businesses thrive through funding, professional support and premises. Unleashing potential, building resilience & championing growth.
Show more...Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Series A
- United Kingdom, United States
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
- RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more...Investment focus
- Software, Biotechnology, Health Care
- Series A, Series B, Series C
- United States, Israel, India
Portfolio highlights
- Acesion Pharma — Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
- Actio Biosciences — At Actio, we are leveraging advances in genetics and precision medicine to develop life-changing treatments that target underlying shared biology between rare and common diseases. We are applying expertise in genetics, drug discovery, and data sciences to pinpoint targets that not only cause rare diseases with high unmet need, but that also hold promise in more common indications.
- Diligent Robotics — We build robots like Moxi that assist hospital staff with routine activities so they can focus on caring for patients.
New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.
Show more...Investment focus
- Software, Health Care, Biotechnology
- Series B, Series A, Series C
- United States, India, China
Portfolio highlights
- Embrace — Stay informed with Embrace's mobile monitoring solutions. Optimize app performance & user experience with our comprehensive platform. Learn more now.
- Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
- Functional Finance — Automated FinOps for Insurance. Unify and automate all of your financial operations, workflows and servicing without replacing your current infrastructure.
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: